An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes

Blood

Volumn 106, Issue 8, 2005, Pages 2781-2789

  Renaudineau, Yves ^b   Hillion, Sophie ^b   Saraux, Alain ^b   Mageed, Rizgar A ^b   Youinou, Pierre ^a  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD5 ANTIGEN; PROTEIN TYROSINE PHOSPHATASE SHP 2;

ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DOWN REGULATION; EXON; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROVIRUS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 27144519226     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-02-0597     Document Type: Article

References (35)

1. Youinou P, Jamin C, Lydyard PM. CD5 expression in human B-cell populations. Immunol Today. 1999;20:312-316.
2. Caligaris-Cappio F, Ghia P. The nature and origin of the B-chronic lymphocytic leukemia: a tentative model. Hematol Oncol Clin North Am. 2004;18:849-862.
3. Caligaris-Cappio F. Biology of chronic lymphocytic leukemia. Rev Clin Exp Hematol. 2000;4:5-21.
4. Tarakhovsky A, Kanner SB, Hombach J, et al. A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science. 1995;269:535-537.
5. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S. CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1B cells. Science. 1996;274:1906-1909.
6. Sen G, Bikah G, Venkataraman C, Bondada S. Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur J Immunol. 1999;29:3319-3328.
7. Kaplan D, Smith D, Myerson H, Pecora N, Leuvandowska K. CD5 expression by B lymphocytes and its regulation upon Epstein-Barr virus transformation. Proc Natl Acad Sci U S A. 2001;98:13850-13853.
8. Azzam HS, Grinberg A, Lui K, Shen H, Shores EW, Love PE. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med. 1998;188:2301-2311.
9. Ying-zi C, Rabin E, Wortis HH. Treatment of murine CD5-B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol. 1991;3:467-476.
10. Berland R, Wortis HH. An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J Immunol. 1998;161:277-285.
11. Kasaian MT, Ikematsu H, Casali P. Identification and analysis of a novel human surface CD5-B lymphocyte subset producing natural antibodies. J Immunol. 1992;148:2690-2702.
12. Lalor PA, Herzenberg LA, Adams S, Stall AM. Feedback regulation of murine Ly-1 B cell development. Eur J Immunol. 1989;19:507-513.
13. Paavonen T, Quartey-Papafio R, Delves PJ, et al. CD5 mRNA expression and autoantibody production in early human B cells immortalized by EBV. Scand J Immunol. 1990;31:269-274.
14. Pers JO, Jamin C, Lydyard PM, Charreire J, Youinou P. The H2 haplotype regulates the distribution of B cells into B-1a, B-1b and B-2 subsets. Immunogenetics. 2002;54:208-211.
15. Pers JO, Jamin C, Youinou P, Charreire J. Role of IL-10 in the distribution of B cell subsets in the mouse B-1 cell population. Eur Cytokine Netw. 2003;14:178-185.
16. Padilla O, Calvo J, Vilà JM, et al. Genomic organization on the human CD5 gene. Immunogenetics. 2000;51:993-1001.
17. Findley HW Jr, Cooper MD, Kim TH, Alvarado C, Ragab AH. Two new acute B lymphoblastic leukemia lines with early B-cell phenotype. Blood. 1982;60:1305-1309.
18. Repaske R, Steele PE, O'Neill RR, Rabson AB, Martin MA. Nucleotide sequence of a full-length human endogenous retroviral segment. J Virol. 1985;54:764-772.
19. Jones NH, Clabby ML, Dialynes DP, Huang HJS, Herzenberg LA, Strominger JL. Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1. Nature. 1986;323:346-349.
20. Pers JO, Berthou C, Porakishvili N, et al. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia. 2002;16:44-52.
21. Renaudineau Y, Nédellec S, Berthou C, Lydyard PM, Pers JO, Youinou P. The CD5-induced apoptosis message is transduced from the lipid rafts through CD79 in some chronic lymphocytic leukemias. Leukemia. 2005;19:223-229.
22. Schulte AM, Lai S, Kurtz A, Czubayko F, Riegel AT, Wellstein A. Human trophoblast and choriocarcinoma expression of the growth factor pleiothrophin attributable to germ-line insertion of an endogenous virus. Proc Natl Acad Sci U S A. 1996;93:14759-14764.
23. MacKenzie L, Lydyard PM. Epitope mapping of the CD5 molecule. In: Knapp W, Dörken B, Rieber EP, et al, eds. Leucocyte Typing IV, White Cell Differentiation Antigens. Oxford, United Kingdom: Oxford University Press; 1989:336-337.
24. Wortis HH, Teutsch M, Higer M, Zheng J, Parker DC. B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci U S A. 1995;92:3348-3352.
25. Hippen KL, Tze LE, Behrens TW. CD5 maintains tolerance in anergic B cells. J Exp Med. 2000;191:883-890.
26. Jamin C, Magadur G, Lamour A, et al. Cell-free CD5 in patients with rheumatoid diseases. Immunol Lett. 1991;31:79-84.
27. Lu X, Axtell RC, Collawn JF, Gibson A, Justement LB, Raman C. AP2 adaptor complex-dependent internalization of CD5: differential regulation in T and B cells. J Immunol. 2002;168:5612-5620.
28. Weichent TR, Schwartz RC. Induction of murine CD5 expression by v-H-ras. Immunology. 1997;90:30-37.
29. Calvo J, Solé J, Simarro M, Vives J, Lozano F. Evolutionarily conserved transcription regulatory elements within the 5′-flanking region of the human CD5 gene. Tissue Antigens. 1996;47:257-261.
30. Klemsz MJ, McKercher SR, Celada A, van Beveren C, Maki RA. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell. 1990;61:113-124.
31. Yang Y, Contag CH, Felsher D, et al. The E47 transcription factor negatively regulated CD5 expression during thymocyte development. Proc Natl Acad Sci U S A. 2004;101:3898-3902.
32. Parra MK, Gee SL, Koury MJ, Mohandas N, Conboy JG. Alternative 5′ exons and differential splicing regulate expression of protein 4.1R isoforms with distinct N-termini. Blood. 2003;101:4164-4171.
33. Grandchamp B, De Verneuil H, Beaumont C, Chrétien S, Walter O, Nordmann Y. Tissue-specific expression of porphobilinogen deaminase: two isoenzymes from a single gene. Eur J Biochem. 1987;162:105-110.
34. Vannucchi AM, Linari S, Lin CS, Koury MJ, Bondurant MC, Migliaccio AR. Increased expression of the distal, but not of the proximal, gata 1 transcripts during differentiation of primary erythroid cells. J Cell Physiol. 1999;180:390-401.
35. Cyster, JG, Goodnow CC. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity. 1995;2:13-24.